Rottapharm Madaus, Meda deal

Meda completed its acquisition of Rottapharm for SEK15.3 billion ($2.1 billion) in cash and 30 million shares valued SEK2.9 billion ($406.4 million) based on Meda’s close of SEK96.70 on Oct. 9, the da...